Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Weikang Bio-Technology Group Co., Inc. Announces Fiscal Year 2011 Financial Results
2012-04-02 21:58
Weikang Bio-Technology Group Co., Inc. Is Expected to Achieve the Net Profit of at Least $26 Million
2012-02-27 21:30
Weikang Bio-Technology Announces Fiscal 2010 Financial Results
2011-03-22 19:00
Weikang Bio-Technology to Present at Rodman & Renshaw Annual China Investment Conference
2011-03-04 21:33
Weikang Bio-Technology Announces Completion of $5.0 Million Private Placement
2011-02-01 22:00
Weikang Bio-Technology Announces Inclusion of Ranitidine Hydrochloride Capsule on National Drug Reimbursement List
2011-02-08 14:53
Weikang Bio-Technology Announces Fourth Quarter Revenue Contribution from Newest Sales Agents
2011-01-24 21:00
Weikang Bio-Technology Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share
2011-01-18 21:00
Weikang Bio-Technology Engages RedChip Companies to Lead Public and Investor Relations Efforts
2011-04-19 21:21
Weikang Bio-Technology Announces Update on Newest Products
2011-01-11 21:00
Weikang Bio-Technology Issues Fiscal 2011 Revenue Guidance of $71 - $82 Million and Net Profit of $27 - $31 million or $0.97 - $1.12 Earnings per Share
2010-11-29 21:30
Weikang Bio-Technology to Present at PHARMCHINA'S 64th National Drug Fair Conference
2010-11-24 20:00
Weikang Bio-Technology Signs Three New Agent Contracts Which are Expected to Add $15 Million in Annual Sales
2010-11-22 20:00
Weikang Bio-Technology Reports Record Third Quarter 2010 Financial Results; Revenue of $17 Million and Non-GAAP Net Income of $6.5 Million or $0.23 Earnings per Share
2010-11-15 20:00
Weikang Bio-Technology to Announce Third Quarter Earnings on Monday, November 15
2010-11-11 20:00
Weikang Bio-Technology Reiterates Fiscal 2010 Revenue Guidance of $55 Million and Net Profit of $21 Million for $0.75 Earnings per Share
2010-10-11 19:00
Weikang Bio-Technology Plans to Launch New Therapeutics in First Quarter 2011
2010-10-04 19:00
Weikang Bio-Technology Launches New Good Health Package
2010-09-30 20:00
Weikang Bio-Technology Issues 2010 and 2011 Fiscal Year Guidance
2010-09-14 23:00
Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010
2010-09-07 20:00
1
2